Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CipherSage应助ee采纳,获得10
2秒前
落霞发布了新的文献求助20
2秒前
Cheung2121发布了新的文献求助10
2秒前
2秒前
STUBLE完成签到,获得积分10
3秒前
Owen应助菠萝吹雪采纳,获得10
4秒前
独特阑香完成签到,获得积分10
5秒前
6秒前
Jasper应助奋斗老鼠采纳,获得10
6秒前
7秒前
羊羊关注了科研通微信公众号
7秒前
开心惜梦完成签到,获得积分10
7秒前
8秒前
雪山飞虹完成签到,获得积分10
10秒前
小李子发布了新的文献求助10
11秒前
Shu完成签到 ,获得积分10
11秒前
新火新茶发布了新的文献求助10
11秒前
科研顺利完成签到,获得积分10
11秒前
Lucas应助香蕉谷芹采纳,获得10
11秒前
落霞发布了新的文献求助20
12秒前
changhao6787完成签到,获得积分10
17秒前
17秒前
17秒前
18秒前
研友_VZG7GZ应助科研通管家采纳,获得10
18秒前
18秒前
无花果应助科研通管家采纳,获得10
18秒前
岚叶应助科研通管家采纳,获得10
18秒前
香蕉觅云应助科研通管家采纳,获得10
18秒前
深情安青应助科研通管家采纳,获得30
18秒前
怡然听兰完成签到,获得积分10
19秒前
whu352完成签到,获得积分10
20秒前
Cuddy完成签到 ,获得积分10
21秒前
21秒前
25秒前
单薄广山发布了新的文献求助10
25秒前
CodeCraft应助柚柚采纳,获得10
27秒前
bsgmsf完成签到,获得积分10
27秒前
桃子完成签到 ,获得积分20
28秒前
Lzy完成签到,获得积分10
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Markov Chain Monte Carlo 5000
Weaponeering: An Introduction Fourth Edition, Volume 1 1000
Advanced Weaponeering Fourth Edition, Volume 2 1000
Evidence Summary. Injection (subcutaneous):op- timal administration 1000
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7494505
求助须知:如何正确求助?哪些是违规求助? 9085914
关于积分的说明 19377995
捐赠科研通 7106346
什么是DOI,文献DOI怎么找? 3249749
关于科研通互助平台的介绍 2419147
邀请新用户注册赠送积分活动 2235461